Navigation Links
aTyr Pharma Honored with Red Herring 100 North America Award for Discovering and Developing Innovative Medicines Based on Physiocrine Biology
Date:6/17/2011

SAN DIEGO, June 17, 2011 /PRNewswire/ -- aTyr Pharma, an innovative protein therapeutics company, announced today that Red Herring has named the company as a winner of the 2011 Red Herring 100 North America Award, a prestigious list honoring the year's most promising private companies. aTyr was recognized for its leadership and innovation in the discovery of Physiocrines and development of Physiocrine-based medicines. Physiocrines are naturally occurring human proteins that possess novel in vivo biological activity as extracellular signaling molecules in known pathways relevant to developing protein therapeutics for a range of diseases.

Dr. John Mendlein, executive chairman of aTyr Pharma, said, "Physiocrine protein pathways represent important new therapeutic intervention points for drug discovery.  aTyr is uncovering the role of Physiocrines from an ancient gene family in modulating human physiology and intervening in disease to develop life-changing medicines for patients with grave conditions."

Physiocrines are a recently elucidated class of endogenous human proteins from amino acyl tRNA synthetases that function as extracellular signaling molecules in a variety of physiologic settings.   As either therapeutic proteins or as targets for antibodies, Physiocrines have the potential to address a wide range of diseases, including high unmet patient needs in blood, immune, and metabolism disorders.

"Choosing the companies with the strongest potential was by no means a small feat," said Alex Vieux, publisher and CEO of Red Herring. "After rigorous contemplation and discussion, we narrowed our list down from hundreds of candidates from across North America to the Top 100 Winners. We believe aTyr Pharma embodies the vision, drive and innovation that define a successful entrepreneurial venture." 

Red Herring 100 North America list has become a mark of distinction for identifying promising new companies and entrepreneurs. The Red Herring 100 winners are evaluated on both quantitative and qualitative criteria, such as technology innovation, quality of management and execution of strategy into their respective industries. Red Herring editors were among the first to recognize that companies such as Facebook, Twitter, Google, Skype, YouTube and eBay would change the way we live and work.

"This award recognizes that the development of Physiocrine-based protein therapeutics is distinct from current protein therapeutic programs," said Dr. Jeff Watkins, CEO of aTyr Pharma. "aTyr possesses a unique opportunity to advance new therapeutic applications from novel mechanisms for the development of innovative, high-impact biologics."

About aTyr Pharma

aTyr Pharma develops biologic therapeutics based on Physiocrines and amino acyl tRNA synthetases and is currently focusing on developing products for hematologic and immune indications. aTyr has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. The company's lead program, Tmax, is in preclinical development. The privately held biotech was founded by Scripps Research Institute Professor Paul Schimmel, a leading amino acyl tRNA synthetase scientist, and is backed by leading life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures. For more information, please visit http://www.atyrpharma.com.


'/>"/>
SOURCE aTyr Pharma
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity
2. Florida Independent Drugstores Attack Mail-Service Pharmacies, Put Profits Ahead of Patients
3. Cubist Pharmaceuticals Applauds Congressman Gingrey for Introducing Legislation to Help Fight Superbug Infections
4. Ferring Pharmaceuticals Inc. Congratulates All 2011 Summer National Senior Games Athletes
5. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
6. Ampio Pharmaceuticals Set to Join Russell 3000 Index
7. PDL BioPharma Completes Regular Quarterly Dividend Payment
8. Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity
9. Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing
10. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
11. Saint-Gobains New C-Flex® ULTRA Pump Tubing for Biopharmaceutical Applications Outperforms the Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Surgical Procedure Volumes: Global Analysis (United States, ... Australia, Canada)" report to their offering. ... an essential tool for healthcare business planners, provides surgical ... looks at surgery trends with an in-depth analysis of ...
Breaking Medicine Technology:
(Date:6/27/2016)... NY (PRWEB) , ... June 27, 2016 , ... ... using cutting edge technology to revolutionize the emergency ambulance transport experience for the ... are aware of how Uber has disrupted the taxi industry through the use ...
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):